Cannabis Stocks Icon

Cannabis Stocks

Cannabis is a psychoactive drug that is a part of the Cannabacaee plant family. In the past few years, acceptance of the drug has risen dramatically. Industry leaders, like Canopy Growth and Curaleaf, are quickly establishing the framework for legal cannabis sales. THC is believed to be the component in cannabis that creates the psychoactive effect, which can be used to treat depression, anxiety, sleeping problems, and a wide range of other issues.

Recent Cannabis Stocks Articles

Sundial Growers Must Show Investors Things Are Better, Not Just Different

Sundial has more time to avoid delisting. But being granted extra time to avoid delisting isn't exactly a catalyst in any sense of the word.

Investment Opportunity Breakdown: Marijuana Stocks

U.S. marijuana legalization has come a long way, but it still has a long way to go. Regardless, marijuana stocks have plenty of potential.

Cannabis Stocks Alert: Why Are SNDL, CGC, TLRY, ACB Stocks Are Getting High Today?

Cannabis stocks are up today as some companies report earnings. Sundial Growers has its own cause to celebrate as its story continues.

SNDL Stock Alert: Why Is Sundial Growers Popping 10% Higher Today?

SNDL stock lives to see another day on the Nasdaq after receiving an 180-day extension. What's next for the marijuana supplier?

Why its Best to Weed Out Sundial Growers Stock From Your Portfolio

SNDL Stock is a highly unattractive investment in an industry where there are plenty of high-growth companies to choose from.

SNDL Stock Alert: What Is Going on With Sundial Growers on Key Deadline Day?

All eyes are on Sundial as today marks the Nasdaq-given deadline for SNDL stock to trade above $1. What's next for the marijuana supplier?

SNDL Stock Pops Ahead of Key Feb. 7 Deadline for Sundial Growers

Delisting fears for investors of SNDL stock are in the full effect. The Canadian marijuana supplier has until Feb. 7 to reach $1.

Bet On Sundial Growers Stock Doubling From Current Levels

Returns from Sundial Grower's investment segment and the expansion of its retail network should serve as positive catalysts for SNDL stock.

Why TLRY Stock Is at a Positive Turning Point

Tilray has high costs to overcome first as it builds its brand recognition in the U.S. market and ahead of the Federal cannabis legalization.

Sundial Growers Running Out of Time to Avoid Nasdaq Delisting

A reverse stock split could bring SNDL stock back in compliance, but the clock is ticking and an obstacle remains.

Embrace the Weakness and Expect Growth for Tilray

Analysts might not be enamored with TLRY stock, but Tilray is venturing into some interesting and potentially lucrative market niches.

Sundial Growers: 4 Key Reasons This Stock Remains Unattractive

SNDL stock is a penny stock that has severe fundamental problems; its low price is not a reason to invest in it now.

You May Want to Give Sundial a Second Chance

Despite bearish sentiment right now for cannabis plays, SNDL stock is an interesting opportunity within the space worthy of your attention.

Tilray Falls Along With Its Burning Free Cash Flow

TLRY stock is likely to keep falling if the company can't start producing positive profits or positive free cash flow.

Tilray Isn’t Your Cannabis Bet for the Long-Haul

Despite some positives, TLRY stock still has plenty to do before it can come close to achieving its $4 billion revenue target by 2024.

7 Stocks Under $10 That Can Double in One Year

Stocks under $10 that have strong fundamentals and can bounce-back by 100% from oversold levels in the next 12-months.

Tilray Stock Dropped, But it Still Has Most of its Growth Priced in

TLRY stock doesn't appear to have the wherewithal to achieve its seemingly insurmountable revenue growth targets.

Sundial Stock Is a Buying Opportunity Thanks to Tax Loss Season

SNDL stock moved sharply lower in recent weeks despite positive news. Here's why Sundial dropped and what will change its fortunes in 2022.

Tilray Stock May Rally in January

Marijuana stocks have plunged once again, making TLRY stock a buy-the-dip candidate. Beware of the company's poor fundamentals, however.